Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 153
Filtrar
1.
J Dairy Sci ; 95(8): 4363-71, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22818449

RESUMO

The objectives of this study were to evaluate efficacy of a 2-dose regimen of ceftiofur crystalline free acid sterile suspension (CCFA-SS) for treatment of acute metritis in lactating dairy cows under field conditions and to provide additional safety and injection site tolerance data for injections at the base of the ear. Cows at 15 dairies with rectal temperature ≥ 39.5°C and fetid uterine discharge ≤ 10 d postcalving were randomly assigned by blocks of 2, based on order of entry and without regard to parity, to treatment with saline (1.5 mL/45.5 kg of body weight, n=509) or CCFA-SS (6.6 mg of ceftiofur equivalents/kg of body weight, n=514). Treatments were administered by subcutaneous injection in the posterior aspect of the ear where it attaches to the head; the first dose was administered on study d 0 and the second dose was administered in the contra lateral ear on study d 3. Rectal temperatures were recorded on study d 1 to 4 and 5 or 6 and cows were clinically evaluated daily from study d 1 to 13. Cows that exhibited increased adverse clinical signs of poor health or complications associated with metritis were categorized as a treatment failure and administered escape therapy. Each cow received a veterinary physical examination on study d 5 or 6 to determine if she should be removed from the study and on study d 14 to determine clinical cure or failure to cure. Clinical cure was defined as rectal temperature <39.5°C and non-fetid and purulent or mucopurulent discharge on study d 14 and no escape therapy administered. The injection procedure was scored after each injection (study d 0 and 3) and injection sites and ear carriage were scored on study d 5 or 6, 14, and 57±3. Of the 1,023 cows enrolled, 7 were completely censored due to protocol deviations and 34 were removed for protocol deviations or medical conditions not related to metritis. Clinical cure rate was higher for CCFA-SS than for saline (74.3 vs. 55.3%) and rectal temperatures for each of study d 1 to 5 or 6 were lower for CCFA-SS than saline. Injection procedure indices showed that CCFA-SS could be practically and safely administered using commercial dairy facilities. Although injection site scores were higher for CCFA-SS than saline at study d 5 or 6 and 14, ≥98.6% of ears were normal on d 57±3. Thus, a 2-dose treatment with CCFA-SS given 72h apart increased metritis clinical cure rate and was well tolerated in dairy cows.


Assuntos
Antibacterianos/administração & dosagem , Doenças dos Bovinos/tratamento farmacológico , Doenças dos Bovinos/microbiologia , Cefalosporinas/administração & dosagem , Endometrite/veterinária , Animais , Temperatura Corporal , Bovinos , Endometrite/tratamento farmacológico , Endometrite/microbiologia , Feminino , Injeções Subcutâneas/veterinária , Lactação
2.
Haemophilia ; 16(5): 726-30, 2010 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-20236353

RESUMO

SUMMARY: Two male first cousins with mild haemophilia A had baseline factor VIII levels of 12-15% and experienced bleeding requiring coagulation factor infusion therapy with trauma and surgical procedures. Both the patients with haemophilia A also had electrocardiographically documented symptomatic paroxysmal atrial fibrillation (PAF) for several years that had become resistant to pharmacological suppression. Radiofrequency ablation was considered in both the cases but deferred considering refusal of consent by the patients to undergo the procedure. Remission of arrhythmias has been reported in patients with iron-overload syndromes. Body iron stores assessed by serum ferritin levels were elevated in both men but neither had the C282Y or H63D genes for haemochromatosis. Calibrated reduction of iron stores by serial phlebotomy, avoiding iron deficiency, was followed by remission of symptomatic PAF in both cases. Iron reduction may be an effective treatment for arrhythmias apart from the classic iron-overload syndromes and deserves further study particularly in patients with bleeding disorders who might be at risk for arrhythmias and other diseases of ageing.


Assuntos
Fibrilação Atrial/etiologia , Fibrilação Atrial/terapia , Hemofilia A/complicações , Sobrecarga de Ferro/complicações , Sobrecarga de Ferro/terapia , Flebotomia , Fator VIII/administração & dosagem , Ferritinas/sangue , Hemofilia A/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
3.
Pharmacol Ther ; 120(1): 71-80, 2008 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-18700152

RESUMO

The discovery of anandamide and 2-arachidonyl glycerol (2-AG) as naturally occurring mammalian endocannabinoids has had important and wide-reaching therapeutic implications. This, to a large extent, ensues from the complexity of endocannabinoid biology. One facet of endocannabinoid biology now receiving increased attention is the cyclo-oxygenase-2 (COX-2) derived oxidation products. Anandamide and 2-AG are oxidized to a range of PG-ethanolamides and PG-glyceryl esters that closely approaches that of the prostaglandins (PGs) formed from arachidonic acid. The pharmacology of these electrochemically neutral PG-ethanolamides (prostamides) and PG-glyceryl esters appears to be unique. No meaningful interaction with natural or recombinant prostanoid receptors is apparent. Nevertheless, in certain cells and tissues, prostamides and PG-glyceryl esters exert potent effects. The recent discovery of selective antagonists for the putative prostamide receptor has been a major advance in further establishing prostamide pharmacology as an entity distinct from prostanoid receptors. Since discovery of the prototype prostamide antagonist (AGN 204396), rapid progress has been made. The latest prostamide antagonists (AGN 211334-6) are 100 times more potent than the prototype and are, therefore, sufficiently active to be used in living animal studies. These compounds will allow a full evaluation of the role of prostamides in health and disease. To date, the only therapeutic application for prostamides is in glaucoma. The prostamide analog, bimatoprost, being the most effective ocular hypotensive drug currently available. Interestingly, PGE(2)-glyceryl ester and its chemically stable analog PGE(2)-serinolamide also lower intraocular pressure in dogs. Nevertheless, the therapeutic future of PGE(2)-glyceryl ester is more likely to reside in inflammation.


Assuntos
Moduladores de Receptores de Canabinoides/química , Moduladores de Receptores de Canabinoides/farmacologia , Ciclo-Oxigenase 2/metabolismo , Endocanabinoides , Animais , Ácidos Araquidônicos/farmacologia , Ácidos Araquidônicos/uso terapêutico , Moduladores de Receptores de Canabinoides/biossíntese , Moduladores de Receptores de Canabinoides/uso terapêutico , Glaucoma/tratamento farmacológico , Glaucoma/patologia , Humanos , Alcamidas Poli-Insaturadas/farmacologia , Alcamidas Poli-Insaturadas/uso terapêutico , Antagonistas de Prostaglandina/farmacologia , Antagonistas de Prostaglandina/uso terapêutico
4.
Br J Pharmacol ; 154(5): 1079-93, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18587449

RESUMO

BACKGROUND AND PURPOSE: A prostamide analogue, bimatoprost, has been shown to be effective in reducing intraocular pressure, but its precise mechanism of action remains unclear. Hence, to elucidate the molecular mechanisms of this effect of bimatoprost, we focused on pharmacologically characterizing prostaglandin FP receptor (FP) and FP receptor variant (altFP) complexes. EXPERIMENTAL APPROACH: FP receptor mRNA variants were identified by reverse transcription-polymerase chain reaction. The FP-altFP4 heterodimers were established in HEK293/EBNA cells co-expressing FP and altFP4 receptor variants. A fluorometric imaging plate reader was used to study Ca2+ mobilization. Upregulation of cysteine-rich angiogenic protein 61 (Cyr61) mRNA was measured by Northern blot analysis, and phosphorylation of myosin light chain (MLC) by western analysis. KEY RESULTS: Six splicing variants of FP receptor mRNA were identified in human ocular tissues. Immunoprecipitation confirmed that the FP receptor is dimerized with altFP4 receptors in HEK293/EBNA cells co-expressing FP and altFP4 receptors. In the studies of the kinetic profile for Ca2+ mobilization, prostaglandin F2alpha (PGF2alpha) elicited a rapid increase in intracellular Ca2+ followed by a steady state phase. In contrast, bimatoprost elicited an immediate increase in intracellular Ca2+ followed by a second phase. The prostamide antagonist, AGN211335, selectively and dose-dependently inhibited the bimatoprost-initiated second phase of Ca2+ mobilization, Cyr61 mRNA upregulation and MLC phosphorylation, but did not block the action of PGF2alpha. CONCLUSION AND IMPLICATIONS: Bimatoprost lacks effects on the FP receptor but may interact with the FP-altFP receptor heterodimer to induce alterations in second messenger signalling. Hence, FP-altFP complexes may represent the underlying basis of bimatoprost pharmacology.


Assuntos
Processamento Alternativo , Amidas/farmacologia , Cloprostenol/análogos & derivados , Dinoprosta/metabolismo , Variação Genética , Receptores de Prostaglandina/efeitos dos fármacos , Receptores de Prostaglandina/metabolismo , Transdução de Sinais/efeitos dos fármacos , Sequência de Aminoácidos , Bimatoprost , Northern Blotting , Western Blotting , Cálcio/metabolismo , Linhagem Celular , Cloprostenol/farmacologia , Proteína Rica em Cisteína 61 , Dimerização , Relação Dose-Resposta a Droga , Olho/efeitos dos fármacos , Olho/metabolismo , Humanos , Proteínas Imediatamente Precoces/metabolismo , Peptídeos e Proteínas de Sinalização Intercelular/metabolismo , Cinética , Dados de Sequência Molecular , Cadeias Leves de Miosina/metabolismo , Fosforilação , RNA Mensageiro/metabolismo , Receptores de Prostaglandina/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transfecção
5.
J Natl Cancer Inst ; 57(6): 1211-6, 1976 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1069859

RESUMO

To investigate the systemic, clinical and laboratory effects of iv polyriboinosinic-polyribocytidylic acid (poly I-poly C), 32 doses of poly I-poly C were administered to 22 patients. Doses between 1 and 10 mg/kg induced the formation of serum interferon (IF) and fever. Whereas a direct relationship was seen between the poly I-poly C dose and fever, serum IF levels were not significantly changed by increasing the dose of poly I-poly C over a log range from 1 to 10 mg/kg. Transient abnormalities were noted in liver function tests in 4 of 13 patients who received greater than 6.0 mg/kg. Other laboratory changes were confined to an increase in the absolute granulocyte count that paralleled fever development and abnormalities in coagulation parameters of 1 patient. In vitro lymphocyte DNA synthesis in response to mitogens was transiently impaired at times corresponding to serum IF appearance. These studies have established dose levels of poly I-poly C that can be safely administered to man with minimal toxicity and result in IF induction.


Assuntos
Interferons/sangue , Leucemia/tratamento farmacológico , Ativação Linfocitária/efeitos dos fármacos , Neoplasias/tratamento farmacológico , Poli I-C/uso terapêutico , Adulto , Idoso , Células Cultivadas , Pré-Escolar , Relação Dose-Resposta a Droga , Feminino , Febre/induzido quimicamente , Humanos , Injeções Intravenosas , Leucemia Mieloide Aguda/sangue , Leucemia Mieloide Aguda/tratamento farmacológico , Contagem de Leucócitos , Fígado/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Neoplasias/sangue , Neutrófilos/efeitos dos fármacos , Poli I-C/administração & dosagem , Poli I-C/efeitos adversos
6.
J Natl Cancer Inst ; 80(2): 90-7, 1988 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-2830407

RESUMO

Mopidamol (RA-233), a derivative of dipyridamole, is a phosphodiesterase inhibitor that has been shown previously to limit progression of malignancy in certain experimental animal models and in a pilot study in humans. RA-233 plus chemotherapy was compared with chemotherapy alone in a 5-year double-blind trial involving 719 patients with advanced carcinomas of the lung and of the colon. RA-233 treatment was associated with a statistically significant prolongation of survival in patients with non-small cell lung cancer (N-SCLC) limited to one hemithorax and with reduction in mean plasma fibrogen concentration. RA-233 was not toxic. The favorable effects on survival could not be explained by any factor other than the RA-233 treatment. In other tumor categories tested, no differences in survival were observed. These results suggest that RA-233 is useful in the treatment of N-SCLC of limited extent. They also suggest that therapeutic intervention aimed at modified intracellular pathways might constitute a novel investigative approach to the treatment of cancer.


Assuntos
Carcinoma/tratamento farmacológico , Neoplasias do Colo/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Mopidamol/uso terapêutico , Pirimidinas/uso terapêutico , Carcinoma/mortalidade , Ensaios Clínicos como Assunto , Neoplasias do Colo/mortalidade , AMP Cíclico/análise , Humanos , Neoplasias Pulmonares/mortalidade , Mopidamol/efeitos adversos , Mopidamol/farmacologia , Oncogenes , Estudos Prospectivos , Distribuição Aleatória
7.
J Am Coll Cardiol ; 37(3): 780-5, 2001 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-11693752

RESUMO

OBJECTIVES: We sought to evaluate the ability of psychiatric anxiety-disorder history to discriminate between women with and without angiographic coronary artery disease (CAD) in a population with chest pain. BACKGROUND: A total of 435 women with chest pain underwent a diagnostic battery including coronary angiography in order to improve testing guidelines for women with suspected CAD. METHODS: Women referred for coronary angiography completed questionnaires assessing prior treatment history for anxiety disorder and current anxiety-related symptoms. Analyses controlled for standard CAD risk factors. RESULTS: Forty-four women (10%) reported receiving prior treatment for an anxiety disorder. This group acknowledged significantly higher levels of autonomic symptoms (e.g., headaches, muscle tension [F = 25.0, p < 0.0011 and higher behavioral avoidance scores (e.g., avoidance of open places or traveling alone by bus [F = 4.2, p < 0.05]) at baseline testing compared with women without prior anxiety problems. Women with an anxiety-disorder history did not differ from those without such a history with respect to the presence of inducible ischemia or use of nitroglycerin, although they were younger and more likely to describe both "tight" and "sharp" chest pain symptoms and to experience back pain and episodes of nocturnal chest pain. Logistic regression results indicated that the positive-anxiety-history group was more likely to be free of underlying significant angiographic CAD (odds ratio = 2.74, 95% confidence interval 1.15 to 6.5, p = 0.03). CONCLUSIONS: Among women with chest pain symptoms, a history of anxiety disorders is associated with a lower probability of significant angiographic CAD. Knowledge of anxiety disorder history may assist in the clinical evaluation of women with chest pain.


Assuntos
Transtornos de Ansiedade/epidemiologia , Dor no Peito/epidemiologia , Doença das Coronárias/epidemiologia , Adulto , Comorbidade , Angiografia Coronária , Doença das Coronárias/diagnóstico por imagem , Feminino , Indicadores Básicos de Saúde , Humanos , Modelos Logísticos , Pessoa de Meia-Idade
8.
Leukemia ; 7 Suppl 1: 21-9, 1993 May.
Artigo em Inglês | MEDLINE | ID: mdl-7683352

RESUMO

The myelodysplastic syndrome (MDS) comprises a group of clonal hematopoietic disorders derived from an abnormality affecting a multipotent hematopoietic stem cell. Despite trials testing numerous agents in patients with MDS, no single drug has yet emerged as the accepted standard of treatment. Observation and supportive care with blood products and antibiotics, when necessary, continue to be the mainstays of therapy. We administered 5-azacytidine, a cell-cycle specific ring analog of the pyrimidine nucleoside cytosine, as a continuous intravenous infusion, 75 mg/m2 per day for 7 days every 4 weeks. Patients had refractory anemia with excess blasts (RAEB) or refractory anemia with excess blasts in transformation (RAEB-T). Responses were seen in 21 (49%) of 43 evaluable patients: five (12%) in complete remission (CR, complete normalization of bone marrow and peripheral blood counts); 11 (25%) in partial remission (PR, > or = 50% restoration of the deficit from normal of all three peripheral blood cell lines, elimination of transfusion requirements, and a decrease in percentage bone marrow blasts by > or = 50% from prestudy values); five (12%) improved (> or = 50% restoration in the deficit from normal of one or more peripheral blood cell lines and/or a > or = 50% decrease in transfusion requirements). A trilineage improvement (CR and PR) occurred in 37% of the patients. The median survival for all patients was 13.3 months and the median duration of remission for those with CR and PR was 14.7 months. Mild to moderate nausea and/or vomiting was the most common side effect (63%). Myelosuppression, either bone marrow hypoplasia or drug related cytopenias requiring a reduction in the dose of azacitidine, occurred in only 33% of the patients. Prior to treatment, bone marrow erythroid progenitor cells were assayed in vitro. Colonies derived from erythroid burst-forming units (BFU-e) were undetectable in one patient and reduced in two. The number of colonies derived from erythroid colony-forming units (CFU-e)) were also reduced in two of the three patients. In the two patients with detectable colony growth prior to treatment, colony number decreased by day 8 of the first cycle, followed by a subsequent increase. Continued treatment with azacitidine led to normalization of the number of CFU-e derived colonies as well as an increase in the number of BFU-e derived colonies. This improvement in erythroid colony number correlated with the spontaneous rise in hemoglobin levels and red cell transfusion independence.(ABSTRACT TRUNCATED AT 400 WORDS)


Assuntos
Anemia Refratária com Excesso de Blastos/tratamento farmacológico , Azacitidina/uso terapêutico , Células Precursoras Eritroides/efeitos dos fármacos , Hematopoese/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Anemia Refratária com Excesso de Blastos/sangue , Azacitidina/administração & dosagem , Azacitidina/efeitos adversos , Transfusão de Sangue , Transfusão de Eritrócitos , Feminino , Humanos , Infusões Intravenosas , Masculino
9.
Arch Intern Med ; 141(10): 1353-4, 1981 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-6943985

RESUMO

In the absence of preexisting pulmonary disease, progressive respiratory failure caused by leukostasis associated with uncontrolled chronic granulocytic leukemia developed in two patients. The conditions of both patients improved dramatically with aggressive leukapheresis. Clinical improvement correlated with decreased pulmonary wedge pressure, while vascular volume remained constant. Continuous-flow cell separation removed numerous immature myeloid cells, replaced them with oxygen-carrying erythrocytes, and maintained a constant blood volume. The course of these two patients demonstrates the use of continuous-flow leukapheresis in an intensive care unit to reduce leukocyte count and manifestations of leukostasis rapidly, while improving the oxygen-carrying capacity of blood, without exposing the patients to dangerously large shifts in fluid volume.


Assuntos
Leucaférese , Leucemia Mieloide/complicações , Insuficiência Respiratória/etiologia , Emergências , Feminino , Humanos , Unidades de Terapia Intensiva , Leucemia Mieloide/sangue , Leucocitose/etiologia , Masculino , Pessoa de Meia-Idade , Circulação Pulmonar , Insuficiência Respiratória/terapia
10.
Exp Hematol ; 5(4): 254-65, 1977.
Artigo em Inglês | MEDLINE | ID: mdl-891665

RESUMO

Erythropoietin stimulates the erythropoietin responsive cell to undergo DNA synthesis and subsequent mitosis. To define further the physiology of this effect, a liquid suspension microculture utilizing mouse fetal liver cells was developed. Tritiated thymidine incorporation into erythroid precursors was found to parallel radiolabeled iron incorporation with peak DNA synthesis occurring after 24 hours of culture. Both tritiated thymidine and iron incorporation were dependent on erythropoietin concentration. The responsiveness to erythropoietin decreased when erythropoietin was withheld and this diminishment in reactivity paralleled a morphological differentiation of the cells. This observation, together with the finding that erythropoietin activity could be removed by absorption with large numbers of cells, suggests the proliferation induced by erythropoietin depends on a specific stage in the differentiation of the red blood cell and may be mediated through a specific cellular receptor.


Assuntos
Divisão Celular/efeitos dos fármacos , Eritropoetina/farmacologia , Fígado/citologia , Animais , Células Cultivadas , DNA/biossíntese , Relação Dose-Resposta a Droga , Fígado/embriologia , Camundongos
11.
Am J Clin Nutr ; 69(4 Suppl): 773S-781S, 1999 04.
Artigo em Inglês | MEDLINE | ID: mdl-10195602

RESUMO

One aim of the Pathways study is to improve the knowledge, attitudes, and behaviors of American Indian children in grades 3-5 regarding physical activity and diet in. This article describes the development of a culturally sensitive, age-appropriate questionnaire to assess these variables. The questionnaire was designed to be administered in the classroom in two 30-min sessions. Questions were developed to assess 4 key areas: physical activity, diet, weight-related attitudes, and cultural identity. Potential questions were written after review of relevant literature and existing questionnaires. Numerous and extensive revisions were made in response to input from structured, semistructured, and informal data collection. Questions were pretested in 32 children in grades 3-5 by using semistructured interviews. Test-retest reliability and the internal consistency of scales were examined in 371 fourth-grade children and subsequently in 145 fourth-grade children. Questions were reviewed by American Indians from the communities involved in the Pathways study several times during the developmental process. The process described here serves as one model for the development of a culturally appropriate tool to assess knowledge, attitudes, and behaviors in American Indian children.


Assuntos
Povo Asiático , Dieta/estatística & dados numéricos , Exercício Físico , Comportamento Alimentar , Conhecimentos, Atitudes e Prática em Saúde , Indígenas Norte-Americanos/estatística & dados numéricos , Obesidade/etnologia , Inquéritos e Questionários/normas , Criança , Proteção da Criança/estatística & dados numéricos , Feminino , Humanos , Indígenas Norte-Americanos/psicologia , Masculino , Obesidade/prevenção & controle , Obesidade/psicologia , Reprodutibilidade dos Testes , Instituições Acadêmicas , Estados Unidos
12.
Am J Clin Nutr ; 69(4 Suppl): 788S-795S, 1999 04.
Artigo em Inglês | MEDLINE | ID: mdl-10195604

RESUMO

The objective of the Pathways physical activity feasibility study was to develop methods for comparing type and amount of activity between intervention and control schools participating in a school-based obesity prevention program. Two methods proved feasible: 1) a specially designed 24-h physical activity recall questionnaire for assessing the frequency and type of activities and 2) use of a triaxial accelerometer for assessing amount of activity. Results from pilot studies supporting the use of these methods are described. Analyses of activity during different segments of the day showed that children were most active after school. The activities reported most frequently (e.g., basketball and mixed walking and running) were also the ones found to be most popular in the study population on the basis of formative assessment surveys. Both the physical activity recall questionnaire and the triaxial accelerometer methods will be used to assess the effects of the full-scale intervention on physical activity.


Assuntos
Povo Asiático , Exercício Físico , Indígenas Norte-Americanos/estatística & dados numéricos , Obesidade/etnologia , Obesidade/prevenção & controle , Projetos de Pesquisa , Calorimetria Indireta , Criança , Proteção da Criança/estatística & dados numéricos , Exercício Físico/fisiologia , Feminino , Frequência Cardíaca , Humanos , Entrevistas como Assunto , Masculino , Monitorização Fisiológica , Movimento , Projetos Piloto , Instituições Acadêmicas , Inquéritos e Questionários , Estados Unidos
13.
Am J Med ; 84(5): 955-9, 1988 May.
Artigo em Inglês | MEDLINE | ID: mdl-3259074

RESUMO

A 66-year-old man with homozygous deficiency of factor VII (less activity than 4 percent of normal) had a minimal hemorrhagic tendency and severe coronary atherosclerosis, and underwent aortocoronary saphenous vein bypass surgery. Although plasma factor VII coagulant activity and cross-reacting material were markedly reduced, comparable amounts of factor VII antigen were detected in peripheral blood mononuclear cells of both the patient and of a normal subject by Western blotting techniques. Accelerated coagulation was observed following brief exposure of the patient's phytohemagglutinin-stimulated peripheral blood mononuclear cells to low concentrations of ambient factor VII in vitro. Evidence indicates that factor VII plays a role in vivo in both hemostasis and atherogenesis and it might be assumed that factor VII deficiency would both predispose to excessive bleeding and forestall atherosclerosis. However, these observations suggest that factor VII-mediated thrombin generation may proceed by partitioning of small amounts of factor VII on tissue factor-expressing cells and that factor VII contained within monocytes may facilitate tissue factor-induced coagulation by these cells. These features may provide efficient coagulation activation despite a deficiency of the plasma coagulant protein. The current results may explain, at least in part, the minimal bleeding tendency, and also the occurrence of thrombosis and atherosclerosis in certain persons with factor VII deficiency.


Assuntos
Ponte de Artéria Coronária , Doença da Artéria Coronariana/complicações , Deficiência do Fator VII/genética , Fator VII/fisiologia , Idoso , Doença da Artéria Coronariana/cirurgia , Deficiência do Fator VII/sangue , Deficiência do Fator VII/complicações , Hemostasia , Hemostasia Cirúrgica , Homozigoto , Humanos , Masculino
14.
Am J Med ; 61(6): 892-6, 1976 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1008073

RESUMO

Thirty-one patients with chronic lymphocytic leukemia were treated with mediastinal radiation. In none of the patients was complete remission achieved; either partial remission or clinical improvement was achieved in 52 per cent, but the duration of response was short. The response rate was 77 per cent for the patients receiving a total radiation dose greater than 3,000 rads and 45 per cent for those receiving less than 3,000 rads. Severe life-threatening toxicity was noted in 11 patients and seven of these patients died; two patients died with progressive disease. Severe toxicity was manifested by one or more of the following: bone marrow aplasia, pancytopenia, gram-negative sepsis, generalized herpes zoster and severe esophagitis. Neither the total dose of radiation nor the dose per week correlated withe the severity of reaction or death.


Assuntos
Leucemia Linfoide/radioterapia , Neoplasias do Mediastino/radioterapia , Mediastino , Lesões por Radiação/etiologia , Radioterapia/efeitos adversos , Idoso , Plaquetas , Feminino , Hemoglobinas/análise , Humanos , Leucemia Linfoide/sangue , Contagem de Leucócitos , Linfonodos/efeitos da radiação , Linfócitos , Masculino , Pessoa de Meia-Idade , Neutrófilos , Remissão Espontânea , Baço/efeitos da radiação
15.
J Med Chem ; 42(3): 497-509, 1999 Feb 11.
Artigo em Inglês | MEDLINE | ID: mdl-9986720

RESUMO

The dicaffeoylquinic acids (DCQAs) and dicaffeoyltartaric acids (DCTAs) are potent and selective inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase. They also inhibit HIV-1 replication at nontoxic concentrations. Since integrase is an excellent target for anti-HIV therapy, structure-activity relationships were employed to synthesize compounds with: (1) improved potency against HIV-1 integrase, (2) improved anti-HIV effect in tissue culture, and (3) increased selectivity as indicated by low cellular toxicity. Thirty-four analogues of the DCTAs and DCQAs were synthesized and tested for cell toxicity, anti-HIV activity, and inhibition of HIV-1 integrase. Seventeen of the 34 analogues had potent activity against HIV-1 integrase ranging from 0. 07 to >10 microM. Seventeen analogues that were synthesized or purchased had no inhibitory activity against integrase at concentrations of 25 microM. Of the biologically active analogues, 7 of the 17 inhibited HIV replication at nontoxic concentrations. The most potent compounds were D-chicoric acid, meso-chicoric acid, bis(3,4-dihydroxydihydrocinnamoyl)-L-tartaric acid, digalloyl-L-tartaric acid, bis(3,4-dihydroxybenzoyl)-L-tartaric acid, dicaffeoylglyceric acid, and bis(3, 4-dihydroxyphenylacetyl)-L-tartaric acid. Anti-HIV activity of the active compounds in tissue culture ranged from 35 to 0.66 microM. Structure-activity relationships demonstrated that biscatechol moieties were absolutely required for inhibition of integrase, while at least one free carboxyl group was required for anti-HIV activity. These data demonstrate that analogues of the DCTAs and the DCQAs can be synthesized which have improved activity against HIV integrase.


Assuntos
Fármacos Anti-HIV/farmacologia , Ácidos Cafeicos , Ácido Clorogênico/análogos & derivados , Ácido Clorogênico/farmacologia , Inibidores de Integrase de HIV/farmacologia , Succinatos , Tartaratos/farmacologia , Replicação Viral/efeitos dos fármacos , Fármacos Anti-HIV/química , Sequência de Bases , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Ácido Clorogênico/química , Clonagem Molecular , Primers do DNA , Resistência Microbiana a Medicamentos/genética , Inibidores de Integrase de HIV/química , HIV-1/efeitos dos fármacos , HIV-1/genética , HIV-1/fisiologia , Humanos , Espectroscopia de Ressonância Magnética , Relação Estrutura-Atividade , Tartaratos/química
16.
J Med Chem ; 35(4): 611-20, 1992 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-1311762

RESUMO

A series of novel 6-fluoro-7-diazabicycloalkylquinolonecarboxylic acids substituted with various C8 (H, F, Cl, N) and N1 (ethyl, cyclopropyl, vinyl, 2-fluoroethyl, 4-fluorophenyl, 2,4-difluorophenyl) substituents, as well as, 9-fluoro-10-diazabicycloalkylpyridobenzoxazinecarboxylic acids, were prepared and evaluated for antibacterial activity against a range of important veterinary pathogenic bacteria. The diazabicycloalkyl side chains investigated at the 7-position (benzoxazine 10-position) include (1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]heptane (2), (1S,4S)-2,5-diazabicyclo[2.2.1]heptane (3), (1R,4R)-5-methyl-2,5-diazabicyclo[2.2.1]heptane (4), 8-methyl-3,8-diazabicyclo[3.2.1]octane (5), 9-methyl-3,9-diazabicyclo[4.2.1]nonane (6), 1,4-diazabicyclo[3.2.2]nonane (7), 1,4-diazabicyclo[3.3.1]nonane (8), and 9-methyl-3,9-diazabicyclo[3.3.1]nonane (9). Among these side chains, in vitro potency was not highly variable; other properties therefore proved more critical to the selection of possible development candidates. However, the relative potencies observed for several of these compounds in mouse, swine, and cattle infection models correlated well with those seen in vitro. A combination of the N1 cyclopropyl group and the C7 (1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl appendage conferred the best overall antibacterial, physiochemical, and pharmacodynamic properties. Hence, danofloxacin (Advocin, 2c) (originally CP-76,136, 1-cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1] hept-2-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid) was selected as a candidate for development as a therapeutic antibacterial agent for veterinary medicine.


Assuntos
Anti-Infecciosos/síntese química , Infecções Bacterianas/veterinária , Fluoroquinolonas , Quinolonas/síntese química , Infecções por Actinobacillus/tratamento farmacológico , Infecções por Actinobacillus/veterinária , Actinobacillus pleuropneumoniae , Aerobiose , Anaerobiose , Animais , Anti-Infecciosos/farmacologia , Anti-Infecciosos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Bovinos , Doenças dos Bovinos/tratamento farmacológico , Feminino , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Positivas/efeitos dos fármacos , Camundongos , Estrutura Molecular , Infecções por Pasteurella/tratamento farmacológico , Infecções por Pasteurella/veterinária , Quinolonas/farmacologia , Quinolonas/uso terapêutico , Relação Estrutura-Atividade , Suínos , Doenças dos Suínos/tratamento farmacológico
17.
Transplantation ; 67(3): 475-8, 1999 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-10030297

RESUMO

BACKGROUND: Successful organ donation has been reported after death from poisonings with cyanide, carbon monoxide, methanol, benzodiazepines, and tricyclic antidepressants. In this report, we describe a case of multiple organ donation from a previously healthy individual who died from poisoning with the long-acting anticoagulant rodenticide, brodifacoum. METHODS: Case report and review of the literature. RESULTS: All organs procured from the poisoned donor functioned adequately, and there were no hemorrhagic complications in any of the recipients. CONCLUSION: This case demonstrates that brodifacoum poisoning is not an absolute contraindication to organ donation from brain-dead patients who have sustained a fatal ingestion.


Assuntos
4-Hidroxicumarinas/intoxicação , Anticoagulantes/intoxicação , Transplante de Órgãos , Intoxicação , Doadores de Tecidos , Adulto , Transplante de Córnea , Evolução Fatal , Feminino , Transplante de Coração , Humanos , Transplante de Rim , Transplante de Fígado , Transplante de Pulmão , Masculino , Pessoa de Meia-Idade , Transplante de Pâncreas , Suicídio
18.
Cancer Lett ; 69(1): 21-5, 1993 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-8481890

RESUMO

Women who have breast cysts with intracystic Na+/K+ < 3 may have a higher risk of developing breast cancer than women who have breast cysts with intracystic Na+/K+ > 3. In this study wide-ranging intracystic concentrations of cathepsin D and pS2 (oestrogen inducible proteins/polypeptides) as well as oestradiol were found. The concentrations of cathepsin D and oestradiol were significantly higher in the low electrolyte ratio cyst group than in the high electrolyte ratio cyst group. No significant difference was found between pS2 concentrations in the two groups. The significantly higher intracystic concentrations of cathepsin D, a mitogenic lysosomal endopeptidase and oestradiol in the low electrolyte ratio group may partly provide an explanation for the higher risk of breast cancer which has been observed in this group of women.


Assuntos
Catepsina D/análise , Cistos/química , Estradiol/análise , Doença da Mama Fibrocística/química , Proteínas Musculares/análise , Proteínas , Feminino , Proteínas de Choque Térmico HSP27 , Proteínas de Choque Térmico , Humanos , Chaperonas Moleculares , Potássio/análise , Sódio/análise
19.
Am J Clin Pathol ; 88(5): 596-602, 1987 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-3673941

RESUMO

Routine blood coagulation tests were performed on 431 consecutive patients enrolled in a study of the role of anticoagulation in cancer treatment (VA Cooperative Study #75). Two hundred sixteen control patients were treated with standard therapy, and 215 patients were treated with standard therapy plus sodium warfarin. At the time of entry into the study, the most common abnormalities were elevated fibrinogen levels, platelet counts, and fibrinopeptide A levels. Serial studies demonstrated a steady increase in platelet count and fibrinogen levels before death. Anticoagulation lowered FPA levels but had no significant effect on fibrinogen levels, platelet counts, or euglobulin clot lysis times. An unexpected finding was a dramatic increase in fibrin split product levels after institution of anticoagulation (means +/- SEM = 42.6 +/- 116.4 vs. 2.9 +/- 7.0 mg/L in control subjects; P less than 0.02). This study supports the presence of subclinical activation of blood coagulation in most patients with cancer. Moreover, the preferential activation of fibrinolysis in anticoagulated patients suggests a role for a vitamin K-dependent factor(s) in the regulation of fibrinolysis in patients with cancer.


Assuntos
Testes de Coagulação Sanguínea , Neoplasias/sangue , Doenças Cardiovasculares/sangue , Doenças Cardiovasculares/tratamento farmacológico , Fibrinogênio/análise , Fibrinopeptídeo A/análise , Humanos , Contagem de Plaquetas , Trombina , Varfarina/uso terapêutico
20.
J Clin Pathol ; 45(8): 731-2, 1992 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1401189

RESUMO

The phosphate concentrations were measured in 41 patients who had multiple myeloma with paraproteinaemia using four different methods to compare the incidence of pseudohyperphosphataemia. The direct acid/molybdate method produced the highest number of anomalous results. The erroneously high phosphate concentration was attributable to the presence of turbidity in the reaction mixture. No association was found between paraprotein type and occurrence of turbidity. The direct acid/molybdate method was unreliable in patients with serum paraproteins and should therefore not be used for the measurement of phosphate concentration in such patients.


Assuntos
Bioquímica/métodos , Mieloma Múltiplo/sangue , Fosfatos/sangue , Humanos , Nefelometria e Turbidimetria , Paraproteínas/metabolismo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa